Soligenix, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SNGX, updated each market day.
SNGX AI Sentiment
AI predicts Soligenix, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Soligenix, Inc. Common Stock
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
Sector
Exchange
Market Cap
$11,748,930
Cap Tier
Employees
14
Headquarters
PRINCETON, NJ
Listed Since
April 5, 1994
Website
SNGX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SNGX Volatility
Soligenix, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
